In the May 18, 2015, Federal Register, FDA published its support for the use of Logical Observation Identifiers Names and Codes ("LOINC") in regulatory submissions to the Center for Drug Evaluation and Research ("CDER") and the Center for Biologics Evaluation and Research ("CBER"). FDA encourages all applicants and sponsors to use LOINC codes for clinical test results in investigational study data to help align data standards in clinical research nationwide. Comments due June 29, 2015.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
